MedTrace Logo

Automatic Volume Calculations During Three-dimensional Sonohysterography.

NCT02710006 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2016-09-07

No results posted yet for this study

Summary

The purpose of this trial is to evaluate the feasibility and reliability of automatic volume calculation of uterine cavity in women with reproductive failures. 3D volumes of uterus and uterine cavity will be acquired during three-dimensional ultrasonography and sonohysterography. After that independent observers will measure offline the uterine cavity volume using automatic volume calculation using SonoAVC general software, and VOCAL software.

Conditions

  • Infertility,
  • Abortions, Spontaneous, Habitual

Interventions

PROCEDURE

Sonohysterography

Sonohysterography, also known as saline infusion sonography, is a special, minimally invasive ultrasound technique. Sonohysterography is a technique in which fluid is injected through the cervix into the uterus, and ultrasound is used to. It provides pictures of the inside of a woman's uterus. Three-dimensional sonohysterography is based on volumetric scanning of uterus and its cavity during saline infusion.

Sponsors & Collaborators

  • Jagiellonian University

    collaborator OTHER

  • University of Sao Paulo

    collaborator OTHER

  • Ludwin & Ludwin Gynecology, Private Medical Center

    lead OTHER

Principal Investigators

  • Artur Ludwin, MD, PhD · Ludwin & Ludwin Gynecology

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
42 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-02-29
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02710006 on ClinicalTrials.gov